Advertisement
Advertisement

Archive

2017: Issue 8 2017 (pp. 1455-1659)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

22 articles
1.

G. Quintavalle (1), F. Riccardi (1), G. F. Rivolta (1), D. Martorana (2), C. Di Perna (1), A. Percesepe (2), A. Tagliaferri (1), on behalf of the Ad-Hoc Study Group

(1) Regional Reference Centre for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy; (2) Genetic Unit, University Hospital of Parma, Parma, Italy

Thromb Haemost 2017 117 8: 1455-1464

https://doi.org/10.1160/TH17-02-0085

[Summary] [PDF] [Pay per view] [Export citation]
2.
Joint assessment in von Willebrand disease
Validation of the Haemophilia Joint Health score and Haemophilia Activities List

K. P. M. van Galen (1), M. A. Timmer (1), P. de Kleijn (1), K. Fischer (1), W. Foppen (2), R. E. G. Schutgens (1), J. Eikenboom (3), K. Meijer (4), M. H. Cnossen (5), K. Fijnvandraat (6), J. G. van der Bom (7), B. A. P. Laros-van Gorkom (8, 9), F. W. G. Leebeek (10), E. P. Mauser-Bunschoten (1), on behalf of the Win study group

(1) Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands; (2) Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands; (3) Department of Thrombosis and Hemostasis and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands; (4) Department of Hematology, University of Groningen, University Medical Center Groningen, The Netherlands; (5) Department of Pediatric Hematology, Erasmus University Medical Center-Sophia Children’s Hospital, Rotterdam, The Netherlands; (6) Department of Pediatric Hematology, Academisch Medisch Centrum, Emma children’s hospital, Amsterdam, The Netherlands; (7) Jon J van Rood Center for Clinical Transfusion Medicine, Sanquin Research, Leiden, The Netherlands; (8) Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; (9) Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands; (10) Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Thromb Haemost 2017 117 8: 1465-1470

https://doi.org/10.1160/TH16-12-0967

[Summary] [PDF] [Pay per view] [Export citation]
3.

S. Lertthammakiat (1), N. Anantasit (1), U. Anurathapan (1), N. Sirachainan (1), P. Kadegasem (1), A. Chuansumrit (1)

(1) Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Thromb Haemost 2017 117 8: 1471-1477

https://doi.org/10.1160/TH16-11-0880

[Summary] [PDF] [Pay per view] [Export citation]
4.

Online Supplementary Material

C. Chen (1), X. Xie, X. Wu (2), Y. Lu (2), X. Wang, W. Wu (2), Y. Hu, Q. Ding

(1) State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (2) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Thromb Haemost 2017 117 8: 1478-1485

https://doi.org/10.1160/TH17-01-0046

[Summary] [PDF] [Pay per view] [Export citation]
5.

Online Supplementary Material

P. Amadio (1), E. Tarantino (1), L. Sandrini (1), E. Tremoli (1), S. S. Barbieri (1)

(1) Centro Cardiologico Monzino, IRCCS, Milan, Italy

Thromb Haemost 2017 117 8: 1486-1497

https://doi.org/10.1160/TH16-12-0968

[Summary] [PDF] [Pay per view] [Export citation]
6.

Online Supplementary Material

D. Leenaerts (1), J. Aernouts (2), P. Van Der Veken (3), Y. Sim (1), A. Lambeir (1), D. Hendriks (1)

(1) Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Wilrijk, Belgium; (2) Laboratory of Biomedical Physics, Department of Physics, University of Antwerp, Wilrijk, Belgium; (3) Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Wilrijk, Belgium

Thromb Haemost 2017 117 8: 1498-1508

https://doi.org/10.1160/TH17-02-0097

[Summary] [PDF] [Pay per view] [Export citation]
7.

C. Wu (1, 2), A. R. Stafford (1, 2), J. C. Fredenburgh (1, 2), J. I. Weitz (1, 2, 3), A. Gils (4), P. J. Declerck (4), P. Y. Kim (1, 2)

(1) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada; (2) Department of Medicine McMaster University, Hamilton, Ontario, Canada; (3) Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada; (4) KU Leuven-University of Leuven, Department of Pharmaceutical and Pharmacological Sciences, Therapeutic and Diagnostic Antibodies, Leuven, Belgium

Thromb Haemost 2017 117 8: 1509-1517

https://doi.org/10.1160/TH17-01-0054

[Summary] [PDF] [Pay per view] [Export citation]
8.

Online Supplementary Material

R. J. Yetman (1), Y. C. Barrett (2), Z. Wang (2), R. Adamczyk (2), J. Wang (2), E. Ramacciotti (2), C. Frost (2)

(1) University of Texas, Houston, Texas, USA; (2) Bristol-Myers Squibb, Princeton, New Jersey, USA

Thromb Haemost 2017 117 8: 1518-1527

https://doi.org/10.1160/TH16-06-0423

[Summary] [PDF] [Pay per view] [Export citation]
9.

D. E. Schmidt (1, 2), M. Bruzelius (1), A. Majeed (1, 3), J. Odeberg (1), M. Holmström (1), A. Ågren (1)

(1) Department of Medicine, Division of Haematology, Coagulation Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; (2) University Medical Center Utrecht, Utrecht, The Netherlands; (3) Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Thromb Haemost 2017 117 8: 1528-1533

https://doi.org/10.1160/TH17-02-0129

[Summary] [PDF] [Pay per view] [Export citation]
10.

Online Supplementary Material

Q. Liang (1), H. Qin (2), Q. Ding (1), X. Xie (3), R. Wu (4), H. Wang (3), Y. Hu (5), X. Wang (1)

(1) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (2) Department of clinical laboratory, Huashan Hospital (North), Fudan University, Shanghai, China; (3) State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (4) Hemophilia Work Group, Beijing Children’s Hospital affiliated to Capital Medical University, Beijing, China; (5) Faculty of Medical Laboratory Science, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Thromb Haemost 2017 117 8: 1534-1548

https://doi.org/10.1160/TH16-10-0794

[Summary] [PDF] [Pay per view] [Export citation]
11.

K. Egan (1, 2), H. O’Connor (3), B. Kevane (2, 3, 4), F. Malone (3, 5), A. Lennon (4), A. Al Zadjali (2), S. Cooley (1), C. Monteith (3, 4), P. Maguire (2, 6), P. B. Szklanna (2, 6), S. Allen (1, 2), N. McCallion (3, 4), F. Ní Áinle (1, 2, 3, 4)

(1) School of Medicine and Medical Sciences, University College Dublin (UCD), Ireland; (2) UCD Conway SPHERE Research Group, Dublin, Ireland; (3) The Rotunda Hospital, Dublin, Ireland; (4) Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland; (5) Royal College of Surgeons in Ireland, Dublin, Ireland; (6) School of Biomolecular and Biomedical Sciences, UCD, Dublin, Ireland

Thromb Haemost 2017 117 8: 1549-1557

https://doi.org/10.1160/TH16-12-0949

[Summary] [PDF] [Pay per view] [Export citation]
12.

Online Supplementary Material

C. Nocella (1, 2), R. Carnevale (2), S. Bartimoccia (3), M. Novo (3), R. Cangemi (3), D. Pastori (3), C. Calvieri (3), P. Pignatelli (3), F. Violi (3)

(1) Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy; (2) Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; (3) Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy

Thromb Haemost 2017 117 8: 1558-1570

https://doi.org/10.1160/TH16-11-0857

[Summary] [PDF] [Pay per view] [Export citation]
13.
Microparticles during long-term follow-up after acute myocardial infarction
Association to atherosclerotic burden and risk of cardiovascular events

Online Supplementary Material

C. Christersson (1), Å. Thulin (2), A. Siegbahn (2)

(1) Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; (2) Clinical Chemistry, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Thromb Haemost 2017 117 8: 1571-1581

https://doi.org/10.1160/TH16-11-0837

[Summary] [PDF] [Pay per view] [Export citation]
14.
Open Access

Online Supplementary Material

C. Schoergenhofer (1), E.- L. Hobl (1), T. Staudinger (2), W. S. Speidl (3), G. Heinz (3), J. Siller-Matula (3), C. Zauner (4), B. Reiter (5), J. Kubica (6), B. Jilma (1)

(1) Department of Clinical Pharmacology, Medical University of Vienna, Austria; (2) Department of Medicine I, Oncology and Hematology, Medical University of Vienna, Austria; (3) Department of Medicine II, Cardiology, Medical University of Vienna, Austria; (4) Department of Medicine III, Hepatology and Gastroenterology, Medical University of Vienna, Austria; (5) Department of Laboratory Medicine, Medical University of Vienna, Austria; (6) Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

Thromb Haemost 2017 117 8: 1582-1587

https://doi.org/10.1160/TH17-03-0154

[Summary] [Free PDF] [Export citation]
15.
Open Access

Online Supplementary Material

N. Pugh (1, 2), B. D. Maddox (1), D. Bihan (1), K. A. Taylor (2), M. P. Mahaut-Smith (3), R. W. Farndale (1)

(1) Department of Biochemistry, University of Cambridge, Cambridge, UK; (2) Department of Biomedical and Forensic Sciences, Anglia Ruskin University, Cambridge, UK; (3) Department of Molecular and Cell Biology, University of Leicester, Leicester, UK

Thromb Haemost 2017 117 8: 1588-1600

https://doi.org/10.1160/TH16-12-0906

[Summary] [Free PDF] [Export citation]
16.

Online Supplementary Material

I. Stroo (1, 2), S. Zeerleder (2, 3), C. Ding (1, 4), B. M. Luken (2), J. J. T. H. Roelofs (5), O. J. de Boer (5), J. C. M. Meijers (6, 7), F. J. Castellino (8), C. van 't Veer (1), T. van der Poll (1, 9)

(1) Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; (2) Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands; (3) Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; (4) Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; (5) Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; (6) Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands; (7) Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; (8) W.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, Indiana, USA; (9) Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Thromb Haemost 2017 117 8: 1601-1614

https://doi.org/10.1160/TH16-12-0920

[Summary] [PDF] [Pay per view] [Export citation]
17.
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas*
A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)

Online Supplementary Material

R. M. Santi (1), M. Ceccarelli (2), E. Bernocco (1), C. Monagheddu (2), A. Evangelista (2), F. Valeri (1), F. Monaco (1), U. Vitolo (3), S. Cortelazzo (4), M. G. Cabras (5), M. Spina (6), L. Baldini (7), C. Boccomini (3), A. Chiappella (3), A. Bari (8), S. Luminari (8), C. Visco (9), M. Calabrese (10), G. Limberti (1), A. Levis (10), L. Contino (1), G. Ciccone (2), M. Ladetto (1)

(1) Division of Hematology, A. O. SS. Antonio e Biagio e Cesare Arrigo of Alessandria, Italy; (2) Unit of Clinical Epidemiology, A. O. U. Città della Salute e della Scienza di Torino, and CPO Piemonte, Italy; (3) Division of Hematology II, A. O. U. Città della Salute e della Scienza of Torino, Italy; (4) Division of Hematology and Bone Marrow Transplantation, Regional Hospital S.Maurizio of Bolzano, Italy; (5) Division of Hematology, Hospital Businco of Cagliari, Italy; (6) Division of Hematology, IRCCS CRO of Aviano, Italy; (7) Division of Hematology, Ospedale Maggiore Policlinico of Milano, University of Milano, Italy; (8) Division of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Italy; (9) Ospedale S. Bortolo, Vicenza, Italy; (10) Fondazione Italiana Linfomi (FIL), Alessandria, Italy

Thromb Haemost 2017 117 8: 1615-1621

https://doi.org/10.1160/TH16-11-0895

[Summary] [PDF] [Pay per view] [Export citation]
18.

Online Supplementary Material

T. van der Hulle (1), N. van Es (2), P. L. den Exter (1), J. van Es (2), I. C. M. Mos (1), R. A. Douma (2), M. J. H. A. Kruip (3), M. M. C. Hovens (4), M. ten Wolde (5), M. Nijkeuter (6), H. ten Cate (7, 8), P. W. Kamphuisen (9), H. R. Büller (2), M. V. Huisman (1), F. A. Klok (1)

(1) Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands; (2) Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands; (3) Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands; (4) Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands; (5) Department of Internal Medicine, Flevoziekenhuis Hospital, Almere, the Netherlands; (6) Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands; (7) Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands; (8) Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands; (9) Department of Vascular Medicine, University Medical Center Groningen, Groningen, the Netherlands

Thromb Haemost 2017 117 8: 1622-1629

https://doi.org/10.1160/TH17-02-0076

[Summary] [PDF] [Pay per view] [Export citation]
19.

A. Alatri (1), L. Mazzolai (1), C. Font (2), A. Tafur (3), R. Valle (4), P. J. Marchena (5), A. Ballaz (6), E. Tiraferri (7), L. Font (8), M. Monreal (9), the RIETE Investigators

(1) Division of Angiology, Lausanne University Hospital, Lausanne, Switzerland; (2) Institut Clinic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain ; (3) Department of Medicine – Cardiology-Vascular Section, Northshore University HealthSystem, Evanston, Illinois, USA; (4) Department of Internal Medicine, Hospital Sierrallana, Santander, Spain; (5) Department of Internal Medicine and Emergency, Parc Sanitari Sant Joan de Deu-Hospital General, Barcelona, Spain; (6) Department of Pneumology, Hospital de Galdakao, Vizcaya, Spain; (7) Department of Haemostasis and Thrombosis, Ospedale Infermi, Rimini, Italy; (8) Department of Haematology, Hospital de Tortosa Verge de la Cinta, Tarragona, Spain; (9) Department of Internal Medicine, Hospital Universitario Germans Trias i Pujol de Badalona, Barcelona, Universidad Católica de Murcia, Spain

Thromb Haemost 2017 117 8: 1630-1636

https://doi.org/10.1160/TH17-02-0116

[Summary] [PDF] [Pay per view] [Export citation]
20.

W.-S. Chung (1, 2, 3), C.-L. Lin (4, 5)

(1) Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; (2) Department of Health Services Administration, China Medical University, Taichung, Taiwan; (3) Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan; (4) Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan; (5) College of Medicine, China Medical University, Taichung, Taiwan

Thromb Haemost 2017 117 8: 1637-1643

https://doi.org/10.1160/TH17-01-0039

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-22